TapImmune is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“In pre-clinical animal models, the Company’s vaccine has shown effective restoration of TAP which restores and augments the marker (antigen) presentation and subsequent recognition and killing of cancer cells by the immune system.” Read the following article
TapImmune Inc., incorporated on October 22, 1991, is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers. [Source: Reuters]
Company Website: http://tapimmune.com